Castle Creek Arbitrage’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Castle Creek Arbitrage’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-51,520	Closed	-$39K	–	753
2022 Q3	$39K	Hold	51,520	–	–	﹤0.01%	452
2022 Q2	$4K	Hold	51,520	–	–	﹤0.01%	647
2022 Q1	$10K	Hold	51,520	–	–	﹤0.01%	660
2021 Q4	$29K	Hold	51,520	–	–	﹤0.01%	646
2021 Q3	$33K	Hold	51,520	–	–	﹤0.01%	598
2021 Q2	$57K	Hold	51,520	–	–	﹤0.01%	590
2021 Q1	$46K	Buy	+51,520	New	+$87.1K	﹤0.01%	516

Castle Creek Arbitrage's FLACW Position: Q4 2022 in Review

Castle Creek Arbitrage sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 51,520 shares — an estimated $39K sold.

Castle Creek Arbitrage first reported a position in FLACW in Q1 2021 and held it in 7 quarters. The position peaked at $57K in Q2 2021. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Castle Creek Arbitrage reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Castle Creek Arbitrage sold 51,520 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $39K.
Castle Creek Arbitrage first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 7 quarters.
Castle Creek Arbitrage's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $57K in Q2 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Castle Creek Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.